<SEC-DOCUMENT>0000902664-24-004393.txt : 20240618
<SEC-HEADER>0000902664-24-004393.hdr.sgml : 20240618
<ACCEPTANCE-DATETIME>20240618161106
ACCESSION NUMBER:		0000902664-24-004393
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240618
DATE AS OF CHANGE:		20240618

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		241051868

	BUSINESS ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRIDGER MANAGEMENT, LLC
		CENTRAL INDEX KEY:			0001166309
		ORGANIZATION NAME:           	
		IRS NUMBER:				582553507
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		90 PARK AVENUE, 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		212-918-0820

	MAIL ADDRESS:	
		STREET 1:		90 PARK AVENUE, 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRIDGER MANAGEMENT LLC
		DATE OF NAME CHANGE:	20020130
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BRIDGER MANAGEMENT, LLC -->
          <cik>0001166309</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000818686</issuerCik>
      <issuerName>Teva Pharmaceutical Industries Limited</issuerName>
      <secFileNumber>001-16174</secFileNumber>
      <issuerAddress>
        <com:street1>124 Dvora HaNevi'a St</com:street1>
        <com:city>Tel Aviv</com:city>
        <com:stateOrCountry>L3</com:stateOrCountry>
        <com:zipCode>6944020</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972-3-914-8213</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bridger Management, LLC (1)</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Shareholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Piper Sandler &amp; Co.</name>
        <address>
          <com:street1>1 Greenwich Plaza</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>519000</noOfUnitsSold>
      <aggregateMarketValue>8885280.00</aggregateMarketValue>
      <noOfUnitsOutstanding>1132640597</noOfUnitsOutstanding>
      <approxSaleDate>06/18/2024</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <acquiredDate>06/20/2017</acquiredDate>
      <natureOfAcquisitionTransaction>See Remark 2</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>See Remark 2</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>519000</amountOfSecuritiesAcquired>
      <paymentDate>06/20/2017</paymentDate>
      <natureOfPayment>See Remark 2</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>(1) Bridger Management, LLC ("Bridger") serves as the investment manager of Swiftcurrent Master Fund, Ltd. which holds the shares covered by this Form 144. Roberto Mignone, Founder and Managing Partner of Bridger, is a member of the board of directors of the Issuer. (2) The shares reported herein to be sold were originally acquired through open market purchases on dates ranging from June 20, 2017 to May 10, 2018.</remarks>
    <noticeSignature>
      <noticeDate>06/18/2024</noticeDate>
      <signature>Bridger Management, LLC, By: /s/ Matthew P. Truax, General Counsel and Chief Compliance Officer</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
